CHCuiju He

Cuiju He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cuiju He has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Dehong Luo

    Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    1 shared publication
  • Dong Liang

    Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

    1 shared publication
  • Hairong Zheng

    Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

    1 shared publication
  • Honghong Luo

    Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China

    1 shared publication
  • Jie Wen

    Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China

    1 shared publication
  • Kexin Chen

    Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

    1 shared publication

Latest Publications

  • Open Access

    Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Radiomics Features of Voxel-Wise DCE-MRI Time-Intensity-Curve Profile Maps

    by Ya Ren, Kexin Chen, Meng Wang, Jie Wen, Sha Feng, Honghong Luo, Cuiju He, Yuan Guo, Dehong Luo, Xin Liu, et al.

    Objective: Axillary lymph node (ALN) status in breast cancer is pivotal for guiding treatment and determining prognosis. The study aimed to explore the feasibility and efficacy of a radiomics model using voxel-wise dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) time-intensity-curve (TIC) profile maps to predict ALN metastasis in breast cancer. Methods: A total of 615 breast cancer patients who underwent preoperative DCE-MRI from October 2018 to February 2024 were retrospectively enrolled and randomly allocated into training (n = 430) and testing (n = 185) sets (7:3 ratio). Based on wash-in rate, wash-out enhancement, and wash-out stability, each voxel within manually segmented 3D lesions that were categorized into 1 of 19 TIC subtypes from the DCE-MRI images. Three feature sets were derived: composition ratio (type-19), radiomics features of TIC subtypes (type-19-radiomics), and radiomics features of third-phase DCE-MRI (phase-3-radiomics). Student’s t-test and the least absolute shrinkage and selection operator (LASSO) was used to select features. Four models (type-19, type-19-radiomics, type-19-combined, and phase-3-radiomics) were constructed by a support vector machine (SVM) to predict ALN status. Model performance was assessed using sensitivity, specificity, accuracy, F1 score, and area under the curve (AUC). Results: The type-19-combined model significantly outperformed the phase-3-radiomics model (AUC = 0.779 vs. 0.698, p < 0.001; 0.674 vs. 0.559) and the type-19 model (AUC = 0.779 vs. 0.541, p < 0.001; 0.674 vs. 0.435, p < 0.001) in cross-validation and independent testing sets. The type-19-radiomics showed significantly better performance than the phase-3-radiomics model (AUC = 0.764 vs. 0.698, p = 0.002; 0.657 vs. 0.559, p = 0.037) and type-19 model (AUC = 0. 764 vs. 0.541, p < 0.001; 0.657 vs. 0.435, p < 0.001) in cross-validation and independent testing sets. Among four models, the type-19-combined model achieved the highest AUC (0.779, 0.674) in cross-validation and testing sets. Conclusions: Radiomics analysis of voxel-wise DCE-MRI TIC profile maps, simultaneously quantifying temporal and spatial hemodynamic heterogeneity, provides an effective, noninvasive method for predicting ALN metastasis in breast cancer.